Oncolytics Biotech Inc (ONCY)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Return on Assets (%) | -71.852 | -94.913 | -103.208 | -191.889 | -83.346 | -65.575 | -59.689 | -72.884 |
Return on Equity (%) | -85.624 | -164.615 | -235.334 | -1088.319 | -182.633 | -86.452 | -79.344 | -102.662 |
Return on Invested Capital (%) | -85.578 | -166.666 | -246.444 | -691.843 | -210.736 | -87.015 | -88.221 | -128.299 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.088 | 0.058 | 0.356 | -0.003 | 0.536 | 0.656 | 0.432 | 0.37 |
Earnings Per Share | -0.125 | -0.11 | -0.979 | -0.998 | -0.487 | -0.478 | -0.405 | -0.373 |
Cash Per Share | 0.099 | 0.083 | 0.787 | 0.426 | 0.676 | 0.75 | 0.19 | 0.469 |
Working Capital Per Share | 0.086 | 0.089 | 0.669 | 0.183 | 0.672 | 0.767 | 0.518 | 0.456 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.125 | -0.109 | -0.948 | -0.998 | -0.487 | -0.477 | -0.404 | -0.372 |
EBITDA Per Share | -0.125 | -0.109 | -0.948 | -0.998 | -0.487 | -0.477 | -0.404 | -0.372 |
Free Cash Flow Per Share | -0.126 | -0.11 | -0.978 | -1.012 | -0.497 | -0.481 | -0.41 | -0.378 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 121,26M | 141,81M | 17,4M | 33,2M | 46,17M | 55,04M | 61,33M | 74,42M |
Fin d'année 31 Décembre 2023 | Juin 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Actions en circulation | 57,87M | 61,33M | 62,35M | 65,7M | 73,4M | 74,42M | 75,42M | 76,86M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 70,4M |
Ratio cours/bénéfice | -2,44 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 1,94 |
Ratio prix/valeur comptable | 2,46 |
Rendement de dividende | - |
Actions en circulation | 76,99M |
Volume moyen (1 semaine) | 313,47k |
Volume moyen (1 mois) | 658,41k |
Variation sur 52 semaines | -26,75% |
Plus haut sur 52 semaines | 1,53 |
Plus bas sur 52 semaines | 0,7101 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales